Tech Company Financing Transactions
Verdemed Funding Round
On 4/18/2019, Verdemed secured $12.7 million in funding from private investors.
Transaction Overview
Company Name
Announced On
4/18/2019
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$12,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Verdemed will use the proceeds to complete the acquisition of strategic assets in Colombia and Brazil announced on October 2, 2018, and to continue the development of its business plans in Chile and Mexico.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
2 Bloor St. W
Toronto ON, M5T 1G1
Canada
Toronto ON, M5T 1G1
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Verdemed brings affordable cannabinoid-based pharmaceuticals to doctors and patients in Latin America. Verdemed's mission is to offer the best of approved existing and prospective cannabinoid products to all Latin Americans, in all countries, in all jurisdictions legally authorized to sell medical cannabis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
José Bacellar
Browse more venture capital transactions:
Prev: 4/18/2019: PathAI venture capital transaction
Next: 4/18/2019: ZenGo venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs